Biofunctional coatings and drug-coated stents for restenosis therapy
Palliative therapy utilizing interventional stents, such as vascular stents, biliary stents, esophageal stents, and other stents, has been a prevalent clinical strategy for treating duct narrowing and partial blockage. However, stent restenosis after implantation usually significantly compromises th...
Saved in:
| Main Authors: | Yanghui Wen, Yihuan Li, Rui Yang, Yunjie Chen, Yan Shen, Yi Liu, Xiaomei Liu, Botao Zhang, Hua Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Materials Today Bio |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S259000642400320X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01) -
Drug‐Coated Balloons in In‐Stent Restenosis, a New Standard of Care or Yesterday's News?
by: Nicholas Weight, et al.
Published: (2024-12-01) -
Debulking plus drug-coated balloon angioplasty versus
drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
by: Liqiang Li, et al.
Published: (2022-09-01) -
Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
by: Sacharias von Koch, et al.
Published: (2024-12-01) -
Restenosis risk factors after coronary stenting in metabolic syndrome patients
by: N. M. Danilov, et al.
Published: (2007-04-01)